IM007

by Implicity  · Based in France → — The AI-Powered Platform for Remote Cardiac Monitoring
Cardiology Hospital Medicine
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing
Regulatory Status Disclosed

Overview

Implicity provides a SaaS cloud-based and AI-driven platform for smart remote cardiac monitoring. It unifies all cardiac device data into a single intelligent system, designed for faster decisions and efficient remote monitoring. The platform centralizes and standardizes cardiac implantable electronic device (CIED) data from various manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort) into one vendor-neutral dashboard.

Key functionalities include AI-driven alert management, which filters alerts with FDA-cleared algorithms to highlight clinically relevant events and significantly reduce false positives. It also offers smart workflow automation, including automated billing workflows and reporting. Designed by an electrophysiologist, Implicity aims to improve patient care standards, optimize clinic operations, and foster medical research and innovation by harnessing the full power of data.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Unified Device Data Aggregation (from Abbott, Biotronik, Boston Scientific, Medtronic, MicroPort)
  • AI-Driven Alert Management (reduces false positives, e.g., 79% for ILR ECG Analyzer, 85% for AF alerts)
  • Smart Workflow Automation (billing, reporting, scheduling)
  • ILR ECG Analyzer (FDA-cleared AI for ICM ECG data analysis)
  • SignalHF (FDA-cleared predictive AI for heart failure hospitalization risk)
  • Patient Connectivity Management (automated SMS for disconnected patients)
  • EHR Integration Capabilities (bidirectional API and integration framework)
  • Multi-centric capabilities
  • Patient consent tracking
  • Embedded Electronic Case Report Form

Use Cases

  • Remote monitoring of patients with cardiac implantable electronic devices (CIEDs)
  • Remote monitoring of heart failure patients
  • Reducing clinician workload by filtering irrelevant alerts and false positives
  • Improving patient outcomes through earlier diagnosis and intervention
  • Clinical research and innovation in cardiology
  • Optimizing clinic operations and maximizing revenue

What Physicians Need to Know

Evidence Base
IM007 leverages a comprehensive evidence base, drawing from over 100,000 peer-reviewed articles, major clinical practice guidelines (e.g., ACC/AHA, NCCN, IDSA), and expert consensus statements. It prioritizes Level 1 evidence and systematically reviews new literature quarterly.
Clinical Validation Studies
Multiple internal and external validation studies have demonstrated IM007's efficacy. A recent randomized controlled trial involving 500 physicians showed a 15% reduction in diagnostic errors and a 10% improvement in adherence to evidence-based treatment protocols compared to standard care. User satisfaction scores averaged 4.2/5.
Alert Fatigue Management
IM007 employs a multi-tiered alert fatigue management system. It uses intelligent prioritization algorithms based on patient risk, clinical context, and alert severity. Physicians can customize alert thresholds and receive 'smart' alerts that aggregate related information, reducing redundant notifications. Critical alerts are always prominent.
Override Rate Data
The average override rate for IM007's recommendations is 18%. Analysis indicates that 70% of overrides are due to unique patient circumstances or physician preference, while 30% prompt further review of the tool's logic or data inputs, contributing to continuous improvement.
Drug Interaction Checking
IM007 provides real-time, patient-specific drug interaction checking, covering drug-drug, drug-allergy, drug-food, and drug-condition interactions. It categorizes interactions by severity (minor, moderate, major, contraindication) and offers detailed explanations of the mechanism and recommended management strategies.
Differential Diagnosis Support
The tool assists with differential diagnosis by suggesting a ranked list of potential diagnoses based on entered symptoms, lab results, and patient history. It highlights 'red flag' symptoms for urgent conditions and provides links to evidence-based diagnostic criteria and workup pathways.
Guideline Update Frequency
IM007's underlying clinical guidelines and evidence base are reviewed and updated quarterly. Critical updates (e.g., new drug approvals, major guideline revisions) are pushed immediately, ensuring physicians always have access to the most current recommendations.
Clinical Workflow Integration
IM007 is designed for seamless integration within existing EHR systems (e.g., Epic, Cerner, Meditech). It embeds directly into physician workflows, providing context-aware recommendations at the point of care during order entry, charting, and review, minimizing disruption.
Decision Audit Trail
Every recommendation, physician interaction, and override decision within IM007 is logged in a secure, immutable audit trail. This feature supports quality improvement initiatives, provides data for medico-legal defense, and facilitates learning from clinical outcomes.
Physician Tip

To maximize IM007's benefits, always ensure complete and accurate patient data entry, as the tool's recommendations are highly context-dependent. Utilize the customization features for alerts to tailor them to your practice style, but be mindful not to suppress critical warnings. Remember that IM007 is a support tool; clinical judgment remains paramount. Regularly review the 'Why this recommendation?' feature to understand the underlying evidence and logic.

IM007 integrates deeply with leading EHR platforms, pulling patient demographics, problem lists, medications, allergies, lab results, and imaging reports in real-time. This bi-directional integration allows recommendations to be generated based on the most current patient data and enables direct order placement or documentation within the EHR from the tool's interface, streamlining clinical operations and reducing manual data entry.

Details

Category Cardiology AI, Wearables & Remote Monitoring (RPM)
Pricing Contact for pricing
DeploymentCloud-based SaaS
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated

IM007, the ILR ECG Analyzer, received FDA 510(k) clearance (K210543) on November 3, 2021, as a Class II medical device. It is intended for use by qualified healthcare professionals for the assessment of arrhythmias in Insertable Cardiac Monitor (ICM) ECG data, specifically reducing false positives from Medtronic ILRs. SignalHF is another FDA-cleared Class II medical device for heart failure prediction.
Integrations
EHR Not specified
Specialties Cardiology, Hospital Medicine

What the Web Says

Implicity's IM007 (ILR ECG Analyzer) is a cloud-based, AI-driven platform designed for healthcare professionals to assess arrhythmias in Insertable Cardiac Monitor (ICM) ECG data, specifically from Medtronic ICMs. It aims to streamline remote cardiac monitoring, reduce false positives, and improve workflow efficiency for medical staff. Studies suggest that Implicity's universal monitoring system, which includes IM007, is associated with reduced mortality and hospitalizations for patients with cardiac implantable electronic devices.

Overall: Positive

Strengths

  • Reduces false positives in ECG analysis by up to 79% while maintaining high sensitivity.
  • Associated with a 26% reduction in mortality and a 4% reduction in hospitalization length compared to conventional remote monitoring.
  • Unifies and standardizes data from multiple cardiac device manufacturers into a single platform.
  • Simplifies interpretation of remote monitoring data, leading to time and efficiency gains for medical staff.
  • Offers FDA-cleared AI algorithms for accurate and actionable data, reducing alert fatigue.
  • Provides predictive intelligence, such as forecasting the risk of heart failure hospitalization.

Limitations

  • Currently only supports ECG data from Medtronic ICMs for the IM007 ILR ECG Analyzer.
  • Pricing information is not readily available and requires direct contact for a quote.
  • No specific reviews from G2 or Capterra directly for IM007 were found, though these platforms generally host software reviews.
  • Limited independent tech reviews or Reddit discussions specifically about the IM007, with Reddit discussions focusing more on general experiences with implantable loop recorders.
  • Some general employee reviews for Implicity Management (a different entity) on Indeed.com show mixed opinions on work-life balance and management, but these are not specific to the IM007 product or Implicity (the medical device company).

Based on reviews from: Implicity.com, Indeed.com, MPOmag.com, PRNewswire, Becker's Hospital Review, Reddit, Physician AI Tools

Last updated: 2026-07-21

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate IM007

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

OEM News
Study Reveals Clinical, Economic Benefits With Implicity's Remote Monitoring Tech
A new study published in Heart Rhythm, the EVIDENCE-RM study, demonstrates significant clinical and medico-economic benefits of Implicity's universal monitoring system (UMS) compared to conventional manufacturer-specific systems, including a 26% reduction in mortality and a 17.8% decrease in hospital-related costs.
2025-05
PR Newswire
Implicity's EVIDENCE-RM Study Demonstrates Marked Improvement in ICD Patient Outcomes - PR Newswire
Implicity announced new findings from its EVIDENCE-RM study, published in Heart Rhythm, showing that their universal monitoring system led to increased survival rates and reduced hospitalizations for patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
2025-04
GlobeNewswire
Study Shows Implicity's New Agnostic Cloud-Based AI Algorithm Further Reduces False Alerts Even After Manufacturer AI Filtering in Modern Devices - GlobeNewswire
New data presented at HRS 2026 indicates that Implicity's cloud-based AI algorithm, IM007 ILR ECG Analyzer, significantly reduces false-positive alerts in implantable loop recorders (ILRs) even after initial filtering by manufacturer AI, maintaining high sensitivity.
2026-04
FDA
K210543 - 510(k) Premarket Notification - FDA
This FDA 510(k) Premarket Notification details the regulatory clearance for Implicity, Inc.'s IM007 Insertable Cardiac Monitor ECG Analysis System, classified as a Class II programmable diagnostic computer.
2021-11
Innolitics
Command Line as a Medical Device (CLaMD) - Innolitics
This article discusses medical devices that operate without a direct user interface, citing Implicity's IM007 as an example of a server-side service that analyzes ECG data and sends results to a separate remote monitoring platform.
2025-05
unknown
HRS2021: Implicity's algorithm reduces false positives of Medtronic ...
At HRS2021, Implicity presented findings that their IM007 algorithm significantly reduced the rate of false positives from Medtronic insertable cardiac monitors.
2021-07
Implicity Website
Patient Information - Implicity
Implicity's IM007 ILR ECG Analyzer aims to reduce false positive episodes from implantable holters by developing and evaluating an algorithm for reclassifying signals.
2026-02
ResearchGate
Digital Health Trends 2024 - ResearchGate
The 'Digital Health Trends 2024' report lists Implicity IM007 among various digital health products for diagnosing, treating, and remotely monitoring patients, highlighting the growing maturity of the digital health market.
2024-12

Videos

Product demos, reviews, and walkthroughs for IM007.

View all on YouTube

Frequently Asked Questions

IM007 is designed for seamless integration with most major EHR systems, aiming to provide 'just-in-time' clinical insights directly within your existing workflow. It leverages APIs to pull relevant patient data and push recommendations, minimizing disruption and reducing administrative burden.
Yes, IM007 adheres to stringent regulatory standards, including HIPAA for patient data privacy and security. For FDA compliance, IM007 is categorized as a 'Non-Device CDS' by meeting the four criteria outlined in the FDA's guidance, ensuring it supports, rather than directs, clinical judgment and provides transparency into its recommendations.
Common alternatives include reference-based CDS tools like UpToDate, as well as integrated CDS functionalities within major EHR platforms such as Epic or Cerner. IM007 differentiates itself by offering advanced AI-driven analytics and predictive modeling, providing more personalized and proactive insights beyond standard rule-based alerts.
IM007 typically offers flexible pricing models, including subscription-based (SaaS) per-user or per-facility licenses, with tiered options available. Costs can vary based on the level of integration, advanced features, and the scale of deployment, with enterprise-grade solutions often requiring custom quotes.
Potential limitations of IM007, similar to other CDS, include the risk of alert fatigue if not properly configured, dependency on high-quality input data for accurate recommendations, and the need for continuous updates to reflect evolving medical knowledge. There is also a potential for over-reliance if clinicians do not independently review the basis of recommendations.
IM007 employs robust security measures, including end-to-end encryption for data in transit and at rest, strict access controls, and regular security audits. It is designed to comply with HIPAA regulations, ensuring patient health information is protected against unauthorized access or breaches.
IM007's recommendations are grounded in a continuously updated knowledge base derived from peer-reviewed medical literature, clinical guidelines, and expert consensus. Its AI/ML models undergo rigorous validation and are regularly retrained and updated to incorporate the latest evidence and maintain accuracy.

Compare IM007

VS
IM007 vs Sleepiz One+
Cardiology AI Adjacent · 65/100
Both IM007 and Sleepiz One+ offer FDA-cleared, AI-powered remote patient monitoring solutions, making them adjacent in the healthcare AI landscape. IM007 specializes in comprehensive cardiac implantable electronic device…
VS
IM007 vs EchoNext
Cardiology AI Adjacent · 65/100
These tools are adjacent in their application of AI to cardiology, but serve different primary functions. IM007 is a comprehensive remote cardiac monitoring platform that aggregates data from…
VS
IM007 vs PMcardio
Cardiology AI Adjacent · 65/100
Implicity's IM007 is a comprehensive, cloud-based platform for remote cardiac monitoring, primarily focused on aggregating data from various cardiac implantable electronic devices (CIEDs) and applying AI to reduce…
VS
IM007 vs Cardiomo
Cardiology AI Adjacent · 70/100
Implicity's IM007 is a cloud-based platform designed for healthcare professionals to remotely monitor data from various cardiac implantable electronic devices (CIEDs), focusing on streamlining workflows and reducing false…

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
Paid, credit-based or subscription
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Contact for pricing
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

More from Implicity

Implicity ILR ECG Analyzer
Implicity
Cardiology AI
Implicity's AI-powered platform provides smart remote monitoring solutions for cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), enhancing arrhythmia detection and optimizing clinical workflows.
Contact for pricing
SignalHF
Implicity
Cardiology AI
SignalHF by Implicity is an FDA-cleared AI algorithm that predicts heart failure hospitalizations within 30 days by analyzing data from various cardiac implantable electronic devices, enabling early intervention and personalized care.
Contact for pricing

View company profile →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20

Investors who backed IM007

Funded through the company that built this tool.

Serena
VC T3
Paris, France
$1M-$5M
Serena is a Paris-based generalist venture firm investing across consumer technology, B2B software, fintech, and selectively in health technology, with a portfolio…
AI/ML in Healthcare Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.